Provision of EAC - Lot 1 (Clinical & Economic Evidence Assessment)

NICE is seeking to commission external assessment centres (EACs) which will provide a range of health technology assessment (HTA) services to support its technology evaluation programmes and related activities (see above). Suppliers must be able to provide all services within Lots 1 and 2, for Lot 3, 3a or 3b to bid for that Lot. Suppliers need to be able to provide only the services within a work package to bid for any of the work packages within Lot 4. Suppliers can bid for one or more Lots.

NICE will consider bids from multidisciplinary centres with knowledge and expertise in health technology assessment, enhanced for Lots 1 and 3 by a close association with frontline clinical services in areas related to medical technologies such as imaging or in vitro diagnostics. Suppliers intending to provide services in Lot 2 will have significant expertise and experience of advanced HTA methods and be able to provide the service in relation to pharmaceuticals, medical, digital and diagnostic technologies.

NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Apply via the NICE EAC Framework 22-25.